Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
RESEARCH TOOLSreports
Radiopharm Theranostics Limited (RAD) Share Forecast & Price Target
2 Followers
See the Price Targets and Ratings of:
RAD Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RAD Stock 12 Month Forecast
There Are No Analyst Ratings for AU:RAD In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
RAD Financial Forecast
Detailed List of Analyst Forecasts
JonesTrading
AU$0.75
Buy
1462.50%
Upside
Initiated
01/04/24
We conducted a call with RAD management in late calendar 4Q23 to discuss the company's progress and expected calendar 2024 catalysts. Patients are currently being screened in the Phase I trial ( NCT05799274 ) of RAD301 (Ga-68-Trivehexin; RAD's peptide-based PET imaging agent targeting αvβ6- integrin) in pancreatic ductal adenocarcinoma (PDAC) with full enrollment (9 patients) expected in 1Q24. Preliminary data is expected in 2Q24.
Best Analysts Covering Radiopharm Theranostics Limited
Which Analyst Should I Follow If I Want to Buy AU:RAD and Sell After:
1 Month
3 Months
1 Year
Success Rate
0/2 ratings generated profit
Average Return
-57.50%
initiated a buy rating 4 months ago
Copying Justin Walsh's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -57.50% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RAD Analyst Recommendation Trends
Rating
Mar 23
Apr 23
Jun 23
Jan 24
Strong Buy
1
2
3
3
Buy
0
0
0
0
Hold
0
0
0
0
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
2
3
3
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
RAD Stock Forecast FAQ
What is AU:RAD’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:RAD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:RAD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Radiopharm Theranostics Limited a Buy, Sell or Hold?
Currently, no data Available
What is Radiopharm Theranostics Limited’s share price target?
Currently, no data Available
What do analysts say about Radiopharm Theranostics Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Radiopharm Theranostics Limited?
To buy shares of AU:RAD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.